CR2


Summary: This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:120650
PHARMGKB IDPA26857
Map Location1q32.2

Gene Categories:

DRUGGABLE GENOME

GO terms in CR2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0001618 virus receptor activity
MF IDA GO:0001848 complement binding
MF IDA GO:0003677 DNA binding
MF NAS GO:0004875 complement receptor activity
MF NAS GO:0004888 transmembrane signaling receptor activity
MF IPI GO:0005515 protein binding
Showing 1 to 6 of 19 rows rows per page

Gene expression in normal tissue: CR2

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 1

Gene-drug pathway distribution

Protein stability and degradation1

Pathways in CR2


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-166658 Complement cascade
reactome R-HSA-168249 Innate Immune System
reactome R-HSA-168256 Immune System
reactome R-HSA-977606 Regulation of Complement cascade
wikipathways WP23 B Cell Receptor Signaling Pathway
wikipathways WP2806 Human Complement System
Showing 1 to 6 of 14 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD309 17AAG 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CR2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​